Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.43 |
| ▸ | SYK | P43405 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | POLB | P06746 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | TPSAB1 | Q15661 | 2/20 | 0.41 |
| ▸ | TPSD1 | Q9BZJ3 | 2/20 | 0.41 |
| ▸ | TPSG1 | Q9NRR2 | 2/20 | 0.41 |
| ▸ | PPARA | Q07869 | 1/20 | 0.40 |
| ▸ | SLC15A1 | P46059 | 1/20 | 0.40 |
| ▸ | ELANE | P08246 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.38 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.38 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.38 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5065711 | 0.91 | ALDH1A1 (0.50) | L3MBTL1ALDH1A1POLBLMNAHSD17B10 | |
| SCHEMBL28721531 | 0.85 | ABCB1 (0.45) | L3MBTL1ALDH1A1POLBLMNAHSD17B10 | |
| SCHEMBL28721530 | 0.85 | ABCB1 (0.45) | L3MBTL1ALDH1A1POLBLMNAHSD17B10 | |
| SCHEMBL8111386 | 0.84 | ALDH1A1 (0.47) | L3MBTL1ALDH1A1POLBLMNAHSD17B10 | |
| SCHEMBL19586697 | 0.82 | TPSAB1 (0.46) | L3MBTL1SYKALDH1A1POLBTPSAB1 | |
| SCHEMBL5182680 | 0.82 | TPSAB1 (0.47) | L3MBTL1SYKALDH1A1TPSAB1TPSD1 | |
| SCHEMBL18076338 | 0.82 | TPSAB1 (0.47) | L3MBTL1SYKALDH1A1TPSAB1TPSD1 | |
| Water SCHEMBL1238348 | 0.81 | TPSAB1 (0.45) | L3MBTL1SYKPOLBTPSAB1TPSD1 | |
| SCHEMBL19456479 | 0.81 | POLB (0.47) | L3MBTL1SYKALDH1A1POLBNPSR1 | |
| SCHEMBL25203184 | 0.81 | POLB (0.45) | L3MBTL1SYKALDH1A1POLBNPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260097062-A1 | AQUEOUS SOLUTIONS CONTAINING PURINES AND PYRIMIDINES AND USES THEREOF | UCB BIOSCIENCES INC (US) | 2026-04-09 | — | — | US | disclosed |
| US-12465615-B2 | Aqueous solutions containing purines and pyrimidines and uses thereof | UCB BIOSCIENCES, INC. (US) | 2025-11-11 | — | — | US | disclosed |
| EP-4313068-A1 | AQUEOUS SOLUTIONS CONTAINING PURINES AND PYRIMIDINES AND USES THEREOF | Zogenix Mds, Inc. (US) | 2024-02-07 | — | — | EP | disclosed |
| CN-117120060-A | Aqueous solutions containing purines and pyrimidines and use thereof | 周格尼克斯-莫迪斯公司 | 2023-11-24 | — | — | CN | disclosed |
| WO-2022204555-A1 | AQUEOUS SOLUTIONS CONTAINING PURINES AND PYRIMIDINES AND USES THEREOF | ZOGENIX MDS, INC. (US) | 2022-09-29 | — | — | WO | disclosed |
| US-20220305041-A1 | AQUEOUS SOLUTIONS CONTAINING PURINES AND PYRIMIDINES AND USES THEREOF | UCB BIOSCIENCES, INC. | 2022-09-29 | — | — | US | disclosed |
| EP-1047665-A1 | MATRIX METALLOPROTEASE INHIBITORS | Pfizer Limited (GB) | 2000-11-02 | — | — | EP | disclosed |
| WO-1999035124-A1 | MATRIX METALLOPROTEASE INHIBITORS | PFIZER LIMITED (GB) | 1999-07-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260097062-A1 | AQUEOUS SOLUTIONS CONTAINING PURINES AND PYRIMIDINES AND USES THEREOF | POLG, POLRMT, TK2 | L3MBTL1 1010/4885SYK 4386/4885ALDH1A1 3723/4885 |
| US-20220305041-A1 | AQUEOUS SOLUTIONS CONTAINING PURINES AND PYRIMIDINES AND USES THEREOF | FPGS, NUDT1, POLRMT | L3MBTL1 1354/4885SYK 3720/4885ALDH1A1 1445/4885 |
| US-12465615-B2 | Aqueous solutions containing purines and pyrimidines and uses thereof | FPGS, NUDT1, POLRMT | L3MBTL1 1354/4885SYK 3720/4885ALDH1A1 1445/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.